# A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients

> **NCT00971997** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 135 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Lispro Mix 50/50

## Key facts

- **NCT ID:** NCT00971997
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2012-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00971997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00971997, "A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00971997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*